Syncope pp 309-327 | Cite as

When and How: Electrophysiological Study (EPS)

  • Michele Brignole
  • David G. Benditt


The gold standard for diagnosis of arrhythmia-induced syncope is correlation of abnormal ECG findings of spontaneous cardiac arrhythmias with symptoms (i.e., syncope). Obtaining such documentation is usually best achieved by ambulatory electrocardiographic (ECG) recording (e.g., “Holter” monitors, “event” recorders, mobile cardiac outpatient telemetry (MCOT), or insertable loop recorders (ILRs)). However, in many patients it may not be possible to obtain such documentation due to the infrequency of symptomatic events, or concerns regarding patient safety should a spontaneous recurrence be associated with a life-threatening circumstance or potential for physical injury. In such cases, electrophysiological study (EPS) may be warranted in an attempt to obtain at least a plausible cause for the symptoms. This is particularly the case in those individuals with an abnormal ECG and/or evidence underlying structural heart disease.


Sinus Node Structural Heart Disease Brugada Syndrome Sinus Node Dysfunction Paroxysmal Supraventricular Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.PubMedCrossRefGoogle Scholar
  2. 2.
    Brignole M, et al. Standardized care pathway vs usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006;8:644–650.PubMedCrossRefGoogle Scholar
  3. 3.
    Benditt DG, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;75(III):93–102.Google Scholar
  4. 4.
    De Sisti A, et al. Electrophysiologic characteristics of the atrium in sinus node dysfunction: atrial refractoriness and conduction. J Cardiovasc Electrophysiol. 2000;11:30–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Yee R, Strauss HC. Electrophysiologic mechanisms: sinus node dysfunction. Circulation. 1987;75(III):12–18.Google Scholar
  6. 6.
    Bergfeldt L, et al. Sinus node recovery time assessment revisited: role of pharmacological blockade of the autonomic nervous system. J Cardiovasc Electrophysiol. 1996;7: 95–101.PubMedCrossRefGoogle Scholar
  7. 7.
    Rothman SA, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007;18:241–247.PubMedCrossRefGoogle Scholar
  8. 8.
    Narula OS, et al. Significance of the sinus-node recovery time. Circulation. 1972;45:140–148.PubMedCrossRefGoogle Scholar
  9. 9.
    de Marneffe M, et al. Variations of normal sinus node function in relation to age: role of autonomic influence. Eur Heart J. 1986;7:662–666.PubMedGoogle Scholar
  10. 10.
    de Marneffe M, et al. The sinus node function: normal and pathological. Eur Heart J. 1993;14:649–654.PubMedCrossRefGoogle Scholar
  11. 11.
    Brignole M. Sick sinus syndrome. Clin Geriatr Med. 2002;18:211–227.PubMedCrossRefGoogle Scholar
  12. 12.
    Gann D, et al. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979;90:24–29.PubMedGoogle Scholar
  13. 13.
    Menozzi C, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavourable outcome. Am J Cardiol. 1998;82:1205–1209.PubMedCrossRefGoogle Scholar
  14. 14.
    Brignole M, et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiologic test. Circulation. 2001;104:2045–2050.PubMedCrossRefGoogle Scholar
  15. 15.
    Menozzi C, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745.PubMedCrossRefGoogle Scholar
  16. 16.
    Moya A, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261–1267.PubMedCrossRefGoogle Scholar
  17. 17.
    Dhingra RC, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation. 1979;60:1455–1464.PubMedCrossRefGoogle Scholar
  18. 18.
    Petrac D, et al. Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. Pacing Clin Electrophysiol. 1996;19:679–687.CrossRefGoogle Scholar
  19. 19.
    Click R, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 1987;59:817–823.PubMedCrossRefGoogle Scholar
  20. 20.
    Gronda M, et al. Electrophysiologic study of atrio-ventricular block and ventricular conduction defects. G Ital Cardiol. 1984;14:768–773.PubMedGoogle Scholar
  21. 21.
    Dini P, et al. Prognostic value of His-ventricular conduction after ajmaline administration. In: Masoni A, Alboni P, eds. Cardiac Electrophysiology Today. London: Academic Press; 1982:pp 515–522.Google Scholar
  22. 22.
    Englund A, et al. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. Pacing Cardiac Electrophysiol. 1998;21:1979–1987.CrossRefGoogle Scholar
  23. 23.
    Fei L, Trohman RG. Advances in cardiac electrophysiology and pacing. Crit Care Clin. 2001;17:337–364.PubMedCrossRefGoogle Scholar
  24. 24.
    Camm AJ, Lau C-P. Syncope of undetermined origin: diagnosis and management. Prog Cardiol. 1988;1:139–156.Google Scholar
  25. 25.
    Moss AJ, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929–2934.PubMedCrossRefGoogle Scholar
  26. 26.
    Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114: e385–e484.PubMedCrossRefGoogle Scholar
  27. 27.
    Priori S. Long QT and Brugada syndromes. From genetics to clinical management. J Cardiovasc Electrophysiol. 2000;11:1174–1180.PubMedCrossRefGoogle Scholar
  28. 28.
    Lacroix D, et al. Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. Am Heart J. 1991;122:1346–1354.PubMedCrossRefGoogle Scholar
  29. 29.
    Knight B, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.PubMedCrossRefGoogle Scholar
  30. 30.
    Link MS, et al. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol. 1997;29:370–375.PubMedCrossRefGoogle Scholar
  31. 31.
    Militianu A, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol. 1997;8:1087–1097.PubMedCrossRefGoogle Scholar
  32. 32.
    Mittal S, et al. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol. 1999;34:1082–1089.PubMedCrossRefGoogle Scholar
  33. 33.
    Andrews N, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1999;34:2023–2030.PubMedCrossRefGoogle Scholar
  34. 34.
    Pires L, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol. 2000;85:725–728.PubMedCrossRefGoogle Scholar
  35. 35.
    Fonarow G, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol. 2000;85: 981–985.PubMedCrossRefGoogle Scholar
  36. 36.
    Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Dipartimento di Cardiologia, Centro AritmologicoOspedali del TigullioLavagnaItaly
  2. 2.Cardiac Arrhythmia CenterMedical School, University of MinnesotaMinneapolisUSA

Personalised recommendations